Search - tctmd.com

Displaying 101 - 120 of 130

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

April 30, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

News Industry News

OrbusNeich’s Genous™ Stent Achieves Complete Endothelialization at Two Weeks

April 20, 2012

News Industry News

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

April 13, 2012

News Industry News

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

February 01, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Industry News

Bard Acquires Lutonix, Inc.

December 19, 2011

News Industry News

Boston Scientific Launches Charger™ PTA Balloon Catheter

December 11, 2011

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

November 10, 2011

News Industry News

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

November 08, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

News Industry News

IVUS Cohort Recruitment Complete in Landmark Tryton IDE Study

October 26, 2011

Advertisement

Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

OrbusNeich’s Genous™ Stent Achieves Complete Endothelialization at Two Weeks

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

Bard Acquires Lutonix, Inc.

Boston Scientific Launches Charger™ PTA Balloon Catheter

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Paclitaxel-coated balloon angioplasty demonstrates superior results

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

IVUS Cohort Recruitment Complete in Landmark Tryton IDE Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content